San Francisco, CA, United States of America

David Scott Johnson

This inventor holds 29 USPTO granted patents and 29 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Recombinant Proteins. Top assignees: Gigagen, Inc., Gigamune, Inc., Natera, Inc.. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Scott Johnson. Retrieved from https://idiyas.com/inventor/david-scott-johnson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 (Patent Applications = 29)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 13)

EPO Patents = 6 (Patent Applications = 22)

Average Co-Inventor Count = 3.5

ph-index = 5

Forward Citations = 339(Granted Patents)

Location History:

Portola Valley, CA (US) (2013)
San Francisco, CA (US) (2016 - 2023)

Company Filing History:

Years Active: 2013-2026

Loading Chart...

Areas of Expertise:

Recombinant Proteins

Polyclonal Proteins

Anti-Viral T Cell Receptors

COVID-19

Zika

Engineered Cells

Fusion Proteins

Single Cell Analysis

Combinatorial Analysis

Nucleic Acids

Genetic Data

Chromosome Copy Number

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12590386 - Recombinant polyclonal proteins and methods of use thereof (2026-03-31),

2. 12497711 - Engineered Cells Expressing Anti-Viral T Cell Receptors and Methods of Use Thereof (2025-12-16),

3. 12421311 - Anti-CTLA-4 binding proteins and methods of use thereof (2025-09-23),

4. 12404607 - Recombinant polyclonal proteins targeting COVID-19 and methods of use thereof (2025-09-02),

5. 12371689 - Engineered enveloped vectors and methods of use thereof (2025-07-29),

6. 12241178 - Recombinant fusion proteins and libraries from immune cell repertoires (2025-03-04),

7. 12195880 - Systems and methods for massively parallel combinatorial analysis of single cells (2025-01-14),

8. 11718660 - Recombinant polyclonal proteins targeting Zika and methods of use thereof (2023-08-08),

9. 11702765 - Recombinant fusion proteins and libraries from immune cell repertoires (2023-07-18),

10. 11685779 - Recombinant polyclonal proteins targeting COVID-19 and methods of use thereof (2023-06-27),

11. 11591652 - System and methods for massively parallel analysis of nucleic acids in single cells (2023-02-28),

12. 11441240 - Systems and methods for massively parallel combinatorial analysis of single cells (2022-09-13),

13. 11427933 - Systems and methods for massively parallel combinatorial analysis of single cells (2022-08-30),

14. 11421220 - Engineered cells expressing anti-viral T cell receptors and methods of use thereof (2022-08-23),

15. 11111490 - Systems and methods for massively parallel combinatorial analysis of single cells (2021-09-07),

Title: The Innovative Journey of David Scott Johnson

Introduction: David Scott Johnson is a renowned inventor based in San Francisco, CA, known for his groundbreaking contributions to various industries through his innovative creations.

Latest Patents: David Scott Johnson holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, David Scott Johnson has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, David Scott Johnson has collaborated with leading companies, research institutions, and universities to bring his inventions to life, fostering a culture of innovation and excellence in every project he undertakes.

Conclusion: David Scott Johnson's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, shaping the future of technology and inspiring generations to come.

Profile summary based on public USPTO records.